Artwork

Content provided by American Academy of HIV Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Academy of HIV Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

IAS 2023 Conference Highlights

36:11
 
Share
 

Manage episode 373183594 series 3383148
Content provided by American Academy of HIV Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Academy of HIV Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Bonus Episode: IAS 2023 Conference Highlights

Dr. William Short and Dr. Laura Armas-Kolostroubis join Bruce to talk about the research coming out of the 12th IAS Conference on HIV Science that took place July 23-26, 2023. They discuss some of the groundbreaking studies presented at the conference and how the research can be translated into clinical practice. They talk about research on zero transmission, studies looking at the next steps in long-acting technologies, and findings from a clinical trial on the use of statins to prevent cardiovascular disease for those with HIV. They also explore the latest on doxycycline PEP for STI prevention and highlight findings from the ANCHOR study on anal cancer and how to prevent it in people with HIV.

About Dr. Short and Dr. Armas-Kolostroubis

William R. Short, MD, MPH, AAHIVS, is an Associate Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania. He is also associate director of the HIV Clinical Trial Unit at the University of Pennsylvania and the co-director of the Clinical Core for the Penn Center for AIDS Research. He is chair of the board of directors of the American Academy of HIV Medicine.

Laura Armas-Kolostroubis, MD, FACP, AAHIVS, is the founder and CEO of Human Centered Consulting and Care. In clinical practice for more than 20 years, Dr. Armas-Kolostroubis was a practicing physician and Chief Medical Officer at CAN Community Health, and she was a clinical director for the Texas/Oklahoma AIDS Education and Training Center. She sits on the board of directors for the American Academy of HIV Medicine.
Resources:

IAS 2023, the 12th IAS Conference on HIV Science - https://www.iasociety.org/conferences/ias2023

ANCHOR Study - https://anchorstudy.org/

REPREIVE Trial - https://www.reprievetrial.org/

********

Questions about this topic? E-mail podcast@aahivm.org to get connected with Bruce or any of our guests.
Are you a medical provider and want to join the conversation? Make your voice heard in the Academy Communities and connect with other HIV clinicians!
To learn more about the Academy, visit www.aahivm.org

  continue reading

12 episodes

Artwork
iconShare
 
Manage episode 373183594 series 3383148
Content provided by American Academy of HIV Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Academy of HIV Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Bonus Episode: IAS 2023 Conference Highlights

Dr. William Short and Dr. Laura Armas-Kolostroubis join Bruce to talk about the research coming out of the 12th IAS Conference on HIV Science that took place July 23-26, 2023. They discuss some of the groundbreaking studies presented at the conference and how the research can be translated into clinical practice. They talk about research on zero transmission, studies looking at the next steps in long-acting technologies, and findings from a clinical trial on the use of statins to prevent cardiovascular disease for those with HIV. They also explore the latest on doxycycline PEP for STI prevention and highlight findings from the ANCHOR study on anal cancer and how to prevent it in people with HIV.

About Dr. Short and Dr. Armas-Kolostroubis

William R. Short, MD, MPH, AAHIVS, is an Associate Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania. He is also associate director of the HIV Clinical Trial Unit at the University of Pennsylvania and the co-director of the Clinical Core for the Penn Center for AIDS Research. He is chair of the board of directors of the American Academy of HIV Medicine.

Laura Armas-Kolostroubis, MD, FACP, AAHIVS, is the founder and CEO of Human Centered Consulting and Care. In clinical practice for more than 20 years, Dr. Armas-Kolostroubis was a practicing physician and Chief Medical Officer at CAN Community Health, and she was a clinical director for the Texas/Oklahoma AIDS Education and Training Center. She sits on the board of directors for the American Academy of HIV Medicine.
Resources:

IAS 2023, the 12th IAS Conference on HIV Science - https://www.iasociety.org/conferences/ias2023

ANCHOR Study - https://anchorstudy.org/

REPREIVE Trial - https://www.reprievetrial.org/

********

Questions about this topic? E-mail podcast@aahivm.org to get connected with Bruce or any of our guests.
Are you a medical provider and want to join the conversation? Make your voice heard in the Academy Communities and connect with other HIV clinicians!
To learn more about the Academy, visit www.aahivm.org

  continue reading

12 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide